Lumentum (LITE) — 2026Q3 FY2026 Earnings Call Analysis

Sold Out at 90% Growth, Racing to Build the Capacity That Ends It

Management is allocating scarce laser supply, raising prices, and simultaneously spending to build the fabs that will erase that pricing power.

Thesis: LITE owns a genuine bottleneck in pump lasers and narrow linewidth lasers with supply-demand imbalance exceeding 30%. Management is allocating capacity, raising prices, and negotiating take-or-pay LTAs with hyperscaler customers. The constraint is physical (indium phosphide fab capacity, Japan wafer fab fully allocated) and the ramp to relieve it takes 4 quarters minimum for pump lasers and 6+ quarters for Greensboro. Near-term pricing power and margin expansion to 35-36% are backed by real undershipping, not channel stuffing.

Verdict: LONG — Conviction: MEDIUM

Catalyst: Q4 guide of $960M-$1.01B at 35-36% operating margin proves the margin trajectory holds even as transceiver mix grows (currently a drag). LTAs with prepayments and take-or-pay structures convert supply constraint into contracted revenue with pricing floors. CPO purchase order delivery in H1 calendar 2027 and scale-out CPO revenue layering in calendar Q4.

Key Risk: Pump laser capacity coming online over the next 4 quarters normalizes supply-demand, reverses price increases, and unwinds the utilization-driven margin expansion. Meanwhile 7.1% share dilution (95.2M to 102M guided) structurally caps EPS even if revenue hits the $2B quarterly target.

The Tell: Hurlston volunteered unprompted that pump laser shortages were 'somewhat unanticipated' and 'hit us relatively suddenly,' having never discussed them in prior quarters. He immediately pivoted to a 4-quarter capacity ramp plan. This admission reveals the constraint is newer and potentially less durable than the narrative implies, while the specific ramp timeline is a commitment he made without analyst prompting.

Detected Patterns

Friction Level: MODERATE_FRICTION — Both sides agree the constraint is real and margins are expanding. The disagreement is timing: does the pricing power persist through the 4-quarter pump laser ramp and Greensboro build, or does capacity normalization reverse margins before the stock reprices?

Report not found

The report data is no longer available. Please return to the archive.

Sold Out at 90% Growth, Racing to Build the Capacity That Ends It | Silicon Signal